Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 681-690 of 2859 for cancer

Edit search filters
  1. A Study To Investigate Efficacy & Safety Of Intratumoral INT230-6 Compared To US Standard Of Care In Adults With Soft Tissue Sarcomas (INVINCIBLE-3)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. Venetoclax And Vincristine Liposomal In Treating Patients With Relapsed Or Refractory T-cell Or B-cell Acute Lymphoblastic Leukemia

    Rochester, MN

  3. A Study To Evaluate AMG 701 In Subjects With Multiple Myeloma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. 3D Ultrasound For The Imaging Of Axillary Lymph Nodes In Patients With Breast Cancer

    Rochester, MN

  5. Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients with Locally Advanced Rectal Cancer Undergoing Surgery

    Eau Claire, WI

  6. A Safety Study Of SEA-TGT (SGN-TGT) In Patients With Advanced Cancer

    Rochester, MN

  7. Ipilimumab With Or Without Talimogene Laherparepvec In Unresected Melanoma

    Jacksonville, FL

  8. Safety And Anti-leukemic Activity Of Vodobatinib (K0706) For Treatment Refractory/Intolerant CML Failing ≥3 Prior Chronic Myeloid Leukemia Therapies

    Jacksonville, FL

  9. A Study To Evaluate Encapsulated Rapamycin To Prevent Progression Of Familial Adenomatous Polyposis In Patients

    Scottsdale/Phoenix, AZ

  10. Pembrolizumab With Or Without Anetumab Ravtansine In Treating Patients With Mesothelin-Positive Pleural Mesothelioma

    Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer